COVID-19Regulatory

U.S. spy agencies collected raw intelligence hinting at public health crisis in Wuhan, China, in November

April 9, 2020 / By Ken Dilanian, Robert Windrem and Courtney Kube

WASHINGTON — U.S. spy agencies collected raw intelligence hinting at a public health crisis in Wuhan, China, in November, two current and one former U.S. official told NBC News, but the information was not understood as the first warning signs of an impending global pandemic.

The intelligence came in the form of communications intercepts and overhead images showing increased activity at health facilities, the officials said. The intelligence was distributed to some federal public health officials in the form of a “situation report” in late November, a former official briefed on the matter said. But there was no assessment that a lethal global outbreak was brewing at that time, a defense official said.

On Wednesday night, the Defense Department disputed an ABC News report that an “intelligence report” had warned about the coronavirus in November.

“We can confirm that media reporting about the existence/release of a National Center for Medical Intelligence (NCMI) Coronavirus-related product/assessment in November of 2019 is incorrect,” said a statement by Dr. R. Shane Day, an Air Force colonel who is director of the National Center for Medical Intelligence, a unit of the Pentagon’s Defense Intelligence Agency. “No such NCMI product exists.”

READ THE REST HERE

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button